Synthesis and Biological Activity of 2-amino-1-aryl-5-(3,3-dimethyl-2-oxobutylidene)-4-oxo-N-(thiazol-5-yl)-4,5-dihydro-1h-pyrrole-3-carboxamides

series of new 2-aminopyrrole derivatives [2-amino-1-aryl-5-(3,3-dimethyl-2-oxobutylidene)-4-oxo- N -(thiazol-5-yl)-4,5-dihydro-1 H -pyrrole-3-carboxamides IIa - h ] were synthesized via the reaction of 4-arylamino-2- tert -butyl-2,5-dihydro-5-oxofuran-2-ylacetates ( Ia - h ) with 2-cyano- N -(thiazol-2-yl)acetamide in the presence of Et 3 N. Studies of the biological activity of the synthesized compounds found that they possessed low toxicity and that 2-amino-1-(2-bromophenyl)-5-(3,3-dimethyl-2-oxobutylidene)-4-oxo- N -(thiazol-5-yl)-4,5-dihydro-1 H -pyrrole-3-carboxamide ( IIb ) and 2-amino-1-(2,4-dichlorophenyl)-5-(3,3-dimethyl-2-oxobutylidene)-4-oxo- N -(thiazol-5-yl)-4,5-dihydro-1 H -pyrrole-3-carboxamide ( IIg ) exhibited radical-binding activity greater than that of trolox and cytotoxic activity against gastrointestinal stromal tumor (GIST) cells, including those resistant to the target drug imatinib (Glivec). The cytotoxic activity of the synthesized compounds was comparable with that of doxorubicin chemotherapeutics and exceeded significantly those of etoposide, paclitaxel, and hydroxyurea. Apossible molecular mechanism of action of the synthesized compounds might be their ability to disrupt cell division and induce selective accumulation of M-phase cells with subsequent death by a mitotic catastrophe pathway.